These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential. Chan AK, Berry LR, Monagle PT, Andrew M. Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942 [Abstract] [Full Text] [Related]
4. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Andrew M, Schmidt B, Mitchell L, Paes B, Ofosu F. Thromb Haemost; 1990 Feb 19; 63(1):27-30. PubMed ID: 2339359 [Abstract] [Full Text] [Related]
5. Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma. Baier K, Cvirn G, Fritsch P, Köstenberger M, Gallistl S, Leschnik B, Muntean W. Pediatr Res; 2005 May 19; 57(5 Pt 1):685-9. PubMed ID: 15718352 [Abstract] [Full Text] [Related]
6. Heparin sensitivity and resistance in the neonate: an explanation. Vieira A, Berry L, Ofosu F, Andrew M. Thromb Res; 1991 Jul 01; 63(1):85-98. PubMed ID: 1658964 [Abstract] [Full Text] [Related]
7. Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma. Novak M, Schlagenhauf A, Bernhard H, Schweintzger S, Leschnik B, Muntean W. Blood Coagul Fibrinolysis; 2011 Oct 01; 22(7):588-92. PubMed ID: 21799400 [Abstract] [Full Text] [Related]
8. alpha 2-Macroglobulin remains as important as antithrombin III for thrombin regulation in cord plasma in the presence of endothelial cell surfaces. Ling X, Delorme M, Berry L, Ofosu F, Mitchell L, Paes B, Andrew M. Pediatr Res; 1995 Mar 01; 37(3):373-8. PubMed ID: 7540283 [Abstract] [Full Text] [Related]
9. Standard assays underestimate the concentration of heparin in neonatal plasma. Schmidt B, Mitchell L, Ofosu F, Andrew M. J Lab Clin Med; 1988 Nov 01; 112(5):641-3. PubMed ID: 3183496 [Abstract] [Full Text] [Related]
10. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency. Herren T, Straub PW, Haeberli A. Thromb Haemost; 1994 Jan 01; 71(1):49-53. PubMed ID: 8165646 [Abstract] [Full Text] [Related]
11. Effects of nadroparin, enoxaparin, and unfractionated heparin on endogenous formation of factor Xa and IIa and on thrombelastometry profiles in cord versus adult blood. Cvirn G, Hoerl G, Tafeit E, Heinl N, Wodrig K, Wagner T, Koestenberger M, Juergens G. Neonatology; 2011 Jan 01; 100(1):23-31. PubMed ID: 21150227 [Abstract] [Full Text] [Related]
12. Effect of covalent serpin-heparinoid complexes on plasma thrombin generation on fetal distal lung epithelium. Berry LR, Klement P, Andrew M, Chan AK. Am J Respir Cell Mol Biol; 2003 Feb 01; 28(2):150-8. PubMed ID: 12540482 [Abstract] [Full Text] [Related]
13. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin. Elgue G, Blombäck M, Olsson P, Riesenfeld J. Thromb Haemost; 1993 Aug 02; 70(2):289-93. PubMed ID: 8236137 [Abstract] [Full Text] [Related]
14. Thrombin inhibition is impaired in plasma of sick neonates. Shah JK, Mitchell LG, Paes B, Ofosu FA, Schmidt B, Andrew M. Pediatr Res; 1992 Apr 02; 31(4 Pt 1):391-5. PubMed ID: 1373886 [Abstract] [Full Text] [Related]
15. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin. Béguin S, Lindhout T, Hemker HC. Thromb Haemost; 1989 Feb 28; 61(1):25-9. PubMed ID: 2749591 [Abstract] [Full Text] [Related]
16. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma. Gallistl S, Muntean W, Leis HJ. Thromb Haemost; 1995 Oct 28; 74(4):1163-8. PubMed ID: 8560429 [Abstract] [Full Text] [Related]
17. An approach to assigning in vitro potency to unfractionated and low molecular weight heparins based on the inhibition of prothrombin activation and catalysis of thrombin inhibition. Ofosu FA, Smith LM, Anvari N, Blajchman MA. Thromb Haemost; 1988 Oct 31; 60(2):193-8. PubMed ID: 2851191 [Abstract] [Full Text] [Related]